Evidence map›Paper›PMID 37291563›Full record

ArticleBMC women's health2023

The relationship of PrEP beliefs to perceived personal, interpersonal and structural benefits and barriers to PrEP use in women who inject drugs.

Kirsten Paulus, Patrick J A Kelly, Jesse Brajuha, Paul D'Avanzo, Emily F Dauria, Aurora Trainor, Annabelle Alrez, Sarah Bauerle Bass

Open access · goldAbstract read
In one paragraph

Article in BMC women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kirsten PaulusDepartment of Social and Behavioral Sciences, Temple University College of Public Health, 1301 Cecil B. Moore Ave., Room 945, Philadelphia, 19064, USA. Kirsten.Paulus@temple.edu.
Patrick J A KellyRisk Communication Laboratory, Temple University College of Public Health, Philadelphia, USA.
Jesse BrajuhaRisk Communication Laboratory, Temple University College of Public Health, Philadelphia, USA.
Paul D'AvanzoDepartment of Social and Behavioral Sciences, Temple University College of Public Health, 1301 Cecil B. Moore Ave., Room 945, Philadelphia, 19064, USA.
Emily F DauriaDepartment of Behavioral and Community Health Sciences, University of Pittsburgh, 130 De Soto Street, Pittsburgh, 15261, USA.
Aurora TrainorDepartment of Social and Behavioral Sciences, Temple University College of Public Health, 1301 Cecil B. Moore Ave., Room 945, Philadelphia, 19064, USA.
Annabelle AlrezDepartment of Social and Behavioral Sciences, Temple University College of Public Health, 1301 Cecil B. Moore Ave., Room 945, Philadelphia, 19064, USA.
Sarah Bauerle BassDepartment of Social and Behavioral Sciences, Temple University College of Public Health, 1301 Cecil B. Moore Ave., Room 945, Philadelphia, 19064, USA.
Temple University · USUniversity of Pittsburgh · US

Funding

Technology Enhanced Substance Use and HIV Service Navigation for Sexual and Gender Minority Young Adults Surveilled by the Carceral SystemR34DA054853 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAURIA, EMILY F · 2022 to 2024
$839k
Development and pilot testing of a PrEP communication intervention and integration into existing HIV testing services for female IV drug using clients of a needle exchangeR34DA046305 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI BASS, SARAH B · 2018 to 2020
$816k
Project kINSHIP: Peer navigators addressing INtersectional Stigma to improve HIV Prevention among criminal-justice involved womenR34DA050480 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAURIA, EMILY F · 2020 to 2022
$735k
NIDA NIH HHS 1R34DA046305-01NIDA NIH HHS R34 DA050480NIDA NIH HHS R34 DA054853
6 · The paper itself

Abstract

backgroundWomen who inject drugs (WWID) have significant biological, behavioral, and gender-based barriers to accessing HIV prevention services, including Pre-Exposure Prophylaxis (PrEP) medication. Little is known about how beliefs about PrEP impact both perceived barriers and benefits of PrEP use and how they may be related to the decision-making process.

methodsSurveys were conducted with 100 female clients of a large syringe services program in Philadelphia, Pennsylvania. The sample was categorized into three groups based on mean PrEP beliefs scores using terciles: accurate beliefs, moderately accurate beliefs, and inaccurate beliefs. Oneway ANOVA tests were used to compare groups by perceived benefits and barriers to PrEP, drug use stigma, healthcare beliefs, patient self-advocacy, and intention to use PrEP.

resultsParticipants had a mean age of 39 years (SD 9.00), 66% reported being White, 74% finished high school, and 80% reported having been homeless within the past 6 months. Those with the most accurate PrEP beliefs reported highest intent to use PrEP and were more likely to agree that benefits of PrEP included it preventing HIV and helping them "feel in charge". Those with inaccurate beliefs were more likely to strongly agree that barriers, such as fear of reprisal from a partner, potential theft, or feeling they "might get HIV anyway", were reasons not to use PrEP.

conclusionsResults indicate perceived personal, interpersonal and structural barriers to PrEP use are associated with accuracy of beliefs is, pointing to important intervention targets to increase uptake among WWID.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdultFemaleHumansIntentionPennsylvaniaSocial StigmaAnti-HIV AgentsDrug useGenderHIV preventionKey and vulnerable populationsPrEPRisk factors

Identifiers

PMID37291563
PMCPMC10251529
OpenAlexW4379967066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.